Dark Mode Light Mode

Keep up to date with the most important news

By pressing the subscribe button, you confirm that you have read and are agreeing to our Privacy policy and Terms of use

Solubility profile of turinabol

Learn about the solubility profile of turinabol, a synthetic anabolic androgenic steroid, and its impact on its absorption and distribution in the body.
Solubility profile of turinabol Solubility profile of turinabol
Solubility profile of turinabol

Solubility Profile of Turinabol

Turinabol, also known as 4-chlorodehydromethyltestosterone, is a synthetic anabolic androgenic steroid (AAS) that was developed in the 1960s by East German scientists. It was initially used to enhance the performance of athletes in the country, but it has since been banned by most sports organizations due to its potential for abuse and adverse health effects. Despite this, turinabol remains a popular choice among bodybuilders and other athletes looking to improve their physical performance.

Pharmacokinetics of Turinabol

Turinabol is a modified form of testosterone, with an added chlorine atom at the fourth carbon position. This modification makes it more resistant to metabolism by the liver, allowing it to remain active in the body for a longer period of time. It is also less androgenic than testosterone, meaning it has a lower potential for causing masculinizing effects such as increased body hair and deepening of the voice.

When taken orally, turinabol is rapidly absorbed into the bloodstream and reaches peak plasma levels within 1-2 hours. It has a half-life of approximately 16 hours, meaning it takes about 16 hours for half of the drug to be eliminated from the body. This relatively long half-life allows for once-daily dosing, making it a convenient option for athletes.

Turinabol is primarily metabolized in the liver, where it undergoes a process called hydroxylation. This results in the formation of several metabolites, including 4-chloro-17α-methyl-δ1-testosterone (M1) and 6β-hydroxy-4-chloro-17α-methyl-δ1-testosterone (M2). These metabolites are then excreted in the urine, with approximately 50% of the drug being eliminated within 24 hours.

Pharmacodynamics of Turinabol

Turinabol works by binding to androgen receptors in the body, which are found in various tissues including muscle, bone, and the central nervous system. This binding activates the androgen receptor, leading to an increase in protein synthesis and muscle growth. It also has a mild anti-catabolic effect, meaning it can help prevent the breakdown of muscle tissue during intense exercise.

One of the unique properties of turinabol is its ability to increase red blood cell production. This is due to its ability to stimulate the production of erythropoietin, a hormone that regulates red blood cell production. This can lead to improved oxygen delivery to muscles, resulting in increased endurance and stamina.

Turinabol also has a low affinity for aromatase, the enzyme responsible for converting testosterone into estrogen. This means that it has a lower potential for causing estrogen-related side effects such as gynecomastia (enlarged breast tissue) and water retention.

Solubility Profile of Turinabol

The solubility of a drug refers to its ability to dissolve in a liquid, usually water. This is an important factor to consider when formulating a drug, as it can affect its absorption and bioavailability. In the case of turinabol, its solubility is relatively low, with a reported solubility of 0.02 mg/mL in water at 25°C.

However, this low solubility does not necessarily mean that turinabol is poorly absorbed. In fact, studies have shown that it has a high bioavailability of approximately 90%, meaning that a large percentage of the drug is able to enter the bloodstream and exert its effects. This is likely due to its lipophilic (fat-loving) nature, which allows it to easily pass through cell membranes and enter the bloodstream.

It is worth noting that the solubility of turinabol can be affected by various factors, such as pH and temperature. For example, a study by Kicman et al. (1992) found that the solubility of turinabol increased at lower pH levels, with a solubility of 0.1 mg/mL at pH 1. This suggests that the drug may be more soluble in the acidic environment of the stomach, which could potentially enhance its absorption.

Real-World Examples

Turinabol has been used by athletes in various sports, including bodybuilding, weightlifting, and track and field. One notable example is the East German Olympic team, who were known to have used turinabol as part of a state-sponsored doping program in the 1970s and 1980s. This led to numerous Olympic medals being stripped and a tarnished reputation for the country’s sports program.

In more recent years, turinabol has been linked to several high-profile doping scandals in the world of mixed martial arts (MMA). In 2016, former UFC heavyweight champion Brock Lesnar tested positive for turinabol in an out-of-competition drug test, resulting in a one-year suspension and a $250,000 fine. In 2019, UFC light heavyweight champion Jon Jones also tested positive for turinabol, leading to a 15-month suspension and the overturning of his victory in the fight where the drug was detected.

Expert Opinion

Despite its potential for abuse and negative consequences, turinabol remains a popular choice among athletes looking to enhance their performance. Its unique pharmacokinetic and pharmacodynamic properties make it a desirable option for those seeking to improve their strength, endurance, and muscle mass. However, it is important for athletes to be aware of the potential risks and side effects associated with turinabol, and to use it responsibly and under the guidance of a healthcare professional.

References

Kicman, A. T., Cowan, D. A., Myhre, L., & Tomten, S. E. (1992). The solubility of 4-chloro-1-dehydro-17α-methyltestosterone in aqueous solutions. Journal of Pharmaceutical and Biomedical Analysis, 10(10-12), 1003-1006.

WADA. (2021). The World Anti-Doping Code. Retrieved from https://www.wada-ama.org/en/content/what-is-prohibited

Wu, C., & Kovac, J. R. (2016). Novel uses for the anabolic androgenic steroids nandrolone and oxandrolone in the management of male health. Current Urology Reports, 17(10), 72.

Keep up to date with the most important news

By pressing the subscribe button, you confirm that you have read and are agreeing to our Privacy policy and Terms of use
Previous Post
Blood glucose monitoring with methyltrenbolone

Blood glucose monitoring with methyltrenbolone